Position: Medical Director 

Number of shares in Navamedic ASA:  0 

Year of birth:  1953 

Experience: 

Spira joined the leadership team following Navamedic’s acquisition of the Parkinson’s franchise he built during his tenure as CEO of Sensidose. Within Sensidose, apart of CEO,  he served in several critical capacities including Medical Director and head of Regulatory Affairs and Pharmacovigilance. Prior to his work at Sensidose, he successfully operated his own international consultancy firm for a decade, providing strategic guidance to both national and global life science organizations. Jack began his industrial career at Pharmacia Biotech, where he transitioned from academic research to play a key role in the successful development, registration and global marketing of recombinant Factor VIII. 

Education:  

MD., PhD (in Tumor Biology) (both from Karolinska Institue).